2005, a pivotal year for Axis-Shield, with strong growth and profitability

COMPETITIVE TECHNOLOGIES, INC. LICENSES
HOMOCYSTEINE ASSAY TO GENZYME



Equal Diagnostics is a subsidiary of Genzyme -





We will have to wait and see if the above results in another ASD license, which is likely given ASD ip is very strong on automated assays for Homocysteine.


Some notable diabetes news -

The Diabetes Control and Complication Trial (DCCT) reported in this week's New England Journal of Medicine -



Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

December 22nd
The decrease in glycosylated hemoglobin values during the DCCT was significantly associated with most of the positive effects of intensive treatment on the risk of cardiovascular disease. Microalbuminuria and albuminuria were associated with a significant increase in the risk of cardiovascular disease -